224 related articles for article (PubMed ID: 34661958)
1. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
3. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
4. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
5. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
6. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
7. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
8. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
10. Outcomes After En Bloc Iliac Vessel Excision and Reconstruction During Pelvic Exenteration.
Brown KG; Koh CE; Solomon MJ; Qasabian R; Robinson D; Dubenec S
Dis Colon Rectum; 2015 Sep; 58(9):850-6. PubMed ID: 26252846
[TBL] [Abstract][Full Text] [Related]
11. [Observational study on perioperative outcomes of pelvic exenteration].
Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126
[No Abstract] [Full Text] [Related]
12. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis.
Peacock O; Smith N; Waters PS; Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
Colorectal Dis; 2020 Jul; 22(7):818-823. PubMed ID: 31961476
[TBL] [Abstract][Full Text] [Related]
16. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration: a review of current issues/controversies.
Shine RJ; Glyn T; Frizelle F
ANZ J Surg; 2022 Nov; 92(11):2822-2828. PubMed ID: 35490337
[TBL] [Abstract][Full Text] [Related]
18. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
19. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]